Latest News


Cancer

Valuable new funds support game-changing cancer research.

Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team. The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia. This form of blood cancer is particularly aggressive, with less .....
Read more

Category: Funding support, Research Excellence

Kolling researchers make promising breakthrough with leukaemia study.

While there has been a great deal of encouraging progress with many cancer treatments over the last decade, the prognosis for people with acute myeloid leukaemia remains dismal, with only 27 per cent of patients surviving more than five years after treatment. Lead researcher Dr Jenny Wang said we have seen a sharp rise in the number of people with the deadly form of blood cancer in recent years and.....
Read more

Category: Funding support, Research Excellence

Running for game-changing research.

Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prestigious Boston Marathon while raising significant funds for cancer research. Gemma crossed the finish line in a sub four hour time as part of the talented team running for the internationally renowned Dana Farber Cancer Institute. Gemma ran her first marathon just after completing six months of chemot.....
Read more

Category: Cardiovascular and Renal Research, Funding support, Research Excellence

Kolling NEWS.

We’re kicking off the year with plenty of encouraging research news. Read on for details about new funding, fascinating research into the link between heart disease and osteoarthritis and promising work into a new diabetes treatment. We also unveil the winners of our travel awards program, generously backed by philanthropic funding. Click here: Kolling NEWS
Read more

Category: Newsletters, Research Excellence

Significant investment in our research announced.

A large collection of research projects will get off the ground following generous funding through the Ramsay Research and Teaching Fund Scheme. The scheme has directed more than $10 million to research on the Royal North Shore Hospital campus over the last 20 years, and this year a further $850,000 will be shared across 17 projects. A diverse range of studies will be supported, strengthening inves.....
Read more

Category: Awards, Funding support, Research Excellence

Crucial funds strengthening our research expertise.

A group of young researchers will have the chance to broaden their skills and establish new collaborations following a funding boost from the Royal North Shore Hospital Scientific Staff Council. The council has awarded 12 travel grants to scientists working within the district and the Kolling Institute. The diverse group of young leaders is driving research progress into heart and kidney disease, c.....
Read more

Category: Funding support, Research Excellence

Technology giving our researchers the edge.

Impressive new infrastructure at the Kolling Institute is set to drive progress with our research into cancer and neuroscience. The equipment includes a digital spatial profiling system, which is regarded as one of the most exciting technological advances globally in the investigation of tissues. The $525,000 instrument has been made possible following a LIEF grant through the Australian Research C.....
Read more

Category: Funding support

Act of generosity continues to deliver hope for those with cancer.

The Kolling Institute hosted a special visit by the family of the late Bill Walsh who donated vital funds to establish a cancer laboratory within the Kolling. His family, including his wife, daughters and grandchildren visited the lab to maintain their strong ties with the research team and meet with Academic Director Professor Jim Elliott. Established in 1980, the Bill Walsh Cancer Research Labora.....
Read more

Category: Funding support, Research Excellence

New approach revolutionising ovarian cancer research.

With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope. The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis. Ovarian cancer is often diagnosed late because the symptoms are vague, like bloating, nausea, indigestion, excessive tiredness, and.....
Read more

Category: New Treatment, Research Excellence

Recognition of our impact on the world stage.

Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study is based on metrics from Scopus, a database o.....
Read more

Category: Research Excellence